A.MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE
Name and address of the manufacturer responsible for batch release
KRKA, d.d., Novo mesto Šmarješka cesta 6
8501 Novo mesto Slovenia
- Clopidogrel bgr (zylagren) - clopidogrel hydrogen sulphate
- Clopidogrel ratiopharm - clopidogrel hydrogen sulphate
- Clopidogrel bms - clopidogrel hydrogen sulphate
- Clopidogrel teva (hydrogen sulphate) - clopidogrel hydrogen sulphate
Prescription drugs listed. Substance: "Clopidogrel hydrogen sulphate"
KRKA - FARMA d.o.o. V. Holjevca 20/E 10450 Jastrebarsko Croatia
The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.
B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
Medicinal product subject to medical prescription.
C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
Periodic Safety Update Reports
The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines
D.CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Risk Management Plan (RMP)